231 related articles for article (PubMed ID: 21073857)
1. Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells.
Ikari A; Sanada A; Sawada H; Okude C; Tonegawa C; Sugatani J
Biochim Biophys Acta; 2011 Jun; 1808(6):1502-8. PubMed ID: 21073857
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979
[TBL] [Abstract][Full Text] [Related]
3. Sodium Citrate Increases Expression and Flux of Mg
Takashina Y; Manabe A; Hasegawa H; Matsunaga T; Endo S; Ikari A
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241394
[TBL] [Abstract][Full Text] [Related]
4. Akt and Mammalian target of rapamycin regulate separate systems of proteolysis in renal tubular cells.
Shen W; Brown NS; Finn PF; Dice JF; Franch HA
J Am Soc Nephrol; 2006 Sep; 17(9):2414-23. PubMed ID: 16885413
[TBL] [Abstract][Full Text] [Related]
5. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells.
Ikari A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
Biochem Biophys Res Commun; 2008 May; 369(4):1129-33. PubMed ID: 18339311
[TBL] [Abstract][Full Text] [Related]
6. Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-α in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
Furukawa C; Fujii N; Manabe A; Matsunaga T; Endo S; Hasegawa H; Ito Y; Yamaguchi M; Yamazaki Y; Ikari A
J Cell Physiol; 2017 Oct; 232(10):2841-2850. PubMed ID: 27925186
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
[TBL] [Abstract][Full Text] [Related]
8. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species Downregulate Transient Receptor Potential Melastatin 6 Expression Mediated by the Elevation of miR-24-3p in Renal Tubular Epithelial Cells.
Hirota C; Takashina Y; Yoshino Y; Hasegawa H; Okamoto E; Matsunaga T; Ikari A
Cells; 2021 Jul; 10(8):. PubMed ID: 34440664
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
Yamane K; Ihn H; Tamaki K
Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
[TBL] [Abstract][Full Text] [Related]
12. Rac1 regulates peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway.
Chen BC; Kang JC; Lu YT; Hsu MJ; Liao CC; Chiu WT; Yeh FL; Lin CH
Mol Immunol; 2009 Mar; 46(6):1179-88. PubMed ID: 19118901
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of transient receptor potential melastatin 6 channel expression by rosiglitazone and all-trans-retinoic acid in erlotinib-treated renal tubular epithelial cells.
Manabe A; Furukawa C; Hasegawa H; Matsunaga T; Endo S; Ikari A
J Cell Physiol; 2019 Jun; 234(6):8951-8962. PubMed ID: 30461012
[TBL] [Abstract][Full Text] [Related]
14. Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.
Takeuchi K; Ito F
J Biol Chem; 2004 Jan; 279(2):892-900. PubMed ID: 14570904
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
18. PI3K signaling mediates diverse regulation of ATF4 expression for the survival of HK-2 cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2014 Feb; 88(2):403-14. PubMed ID: 24057571
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription.
Mireuta M; Darnel A; Pollak M
Growth Factors; 2010 Aug; 28(4):243-55. PubMed ID: 20370577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]